ha 1004 has been researched along with Cerebral Ischemia in 2 studies
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakane, H | 1 |
| Yao, H | 1 |
| Ibayashi, S | 1 |
| Kitazono, T | 1 |
| Ooboshi, H | 1 |
| Uchimura, H | 1 |
| Fujishima, M | 1 |
| Okada, T | 1 |
| Shibuya, M | 1 |
| Suzuki, Y | 1 |
| Ikegaki, I | 1 |
| Kageyama, N | 1 |
| Asano, T | 1 |
| Hidaka, H | 1 |
2 other studies available for ha 1004 and Cerebral Ischemia
| Article | Year |
|---|---|
Protein kinase C modulates ischemia-induced amino acids release in the striatum of hypertensive rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amino Acids; Animals; Brain Ischemia; Corpus Striatum | 1998 |
Effect of the intracellular calcium antagonist HA1004 on cerebral blood flow in rats.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Intracellular Fluid; | 1988 |